A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Becton Dickinson & CO stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 58,991 shares of BDX stock, worth $13.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
58,991
Previous 58,695 0.5%
Holding current value
$13.5 Million
Previous $13.7 Million 3.68%
% of portfolio
0.07%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$221.47 - $242.41 $65,555 - $71,753
296 Added 0.5%
58,991 $14.2 Million
Q2 2024

Aug 13, 2024

SELL
$225.07 - $246.17 $17.9 Million - $19.5 Million
-79,400 Reduced 57.5%
58,695 $13.7 Million
Q1 2024

May 13, 2024

BUY
$233.45 - $247.73 $19.2 Million - $20.4 Million
82,400 Added 147.95%
138,095 $34.2 Million
Q4 2023

Feb 14, 2024

BUY
$232.24 - $267.23 $239,903 - $276,048
1,033 Added 1.89%
55,695 $13.6 Million
Q3 2023

Nov 09, 2023

SELL
$254.9 - $283.59 $1.69 Million - $1.88 Million
-6,630 Reduced 10.82%
54,662 $14.1 Million
Q2 2023

Aug 07, 2023

BUY
$238.39 - $265.32 $2.42 Million - $2.69 Million
10,148 Added 19.84%
61,292 $16.2 Million
Q1 2023

May 11, 2023

SELL
$229.71 - $259.35 $171,593 - $193,734
-747 Reduced 1.44%
51,144 $12.7 Million
Q4 2022

Feb 08, 2023

SELL
$218.29 - $256.91 $37,764 - $44,445
-173 Reduced 0.33%
51,891 $13.2 Million
Q3 2022

Nov 14, 2022

SELL
$51.03 - $264.23 $47,304 - $244,941
-927 Reduced 1.75%
52,064 $11.6 Million
Q2 2022

Aug 10, 2022

SELL
$234.74 - $275.42 $5.56 Million - $6.53 Million
-23,695 Reduced 30.9%
52,991 $13.1 Million
Q1 2022

May 11, 2022

BUY
$243.64 - $270.48 $91,608 - $101,700
376 Added 0.49%
76,686 $19.9 Million
Q4 2021

Feb 10, 2022

SELL
$230.08 - $250.94 $167,498 - $182,684
-728 Reduced 0.94%
76,310 $19.3 Million
Q3 2021

Nov 10, 2021

BUY
$232.72 - $256.47 $3.59 Million - $3.96 Million
15,428 Added 25.04%
77,038 $18.9 Million
Q2 2021

Aug 10, 2021

SELL
$232.65 - $254.58 $833,817 - $912,414
-3,584 Reduced 5.5%
61,610 $15 Million
Q1 2021

May 14, 2021

BUY
$232.09 - $256.88 $972,689 - $1.08 Million
4,191 Added 6.87%
65,194 $15.9 Million
Q4 2020

Feb 11, 2021

BUY
$221.92 - $245.94 $204,610 - $226,756
922 Added 1.53%
61,003 $15.3 Million
Q3 2020

Nov 12, 2020

BUY
$215.77 - $276.76 $1.39 Million - $1.78 Million
6,421 Added 11.97%
60,081 $14 Million
Q2 2020

Aug 13, 2020

SELL
$219.9 - $263.41 $369,651 - $442,792
-1,681 Reduced 3.04%
53,660 $12.8 Million
Q1 2020

May 13, 2020

BUY
$195.69 - $279.01 $61,250 - $87,330
313 Added 0.57%
55,341 $12.7 Million
Q4 2019

Feb 14, 2020

BUY
$236.45 - $266.82 $1.63 Million - $1.84 Million
6,886 Added 14.3%
55,028 $15 Million
Q3 2019

Nov 08, 2019

BUY
$230.58 - $256.08 $50,727 - $56,337
220 Added 0.46%
48,142 $12.2 Million
Q2 2019

Aug 09, 2019

BUY
$217.4 - $246.08 $534,369 - $604,864
2,458 Added 5.41%
47,922 $12.1 Million
Q1 2019

May 15, 2019

SELL
$206.05 - $248.17 $187,711 - $226,082
-911 Reduced 1.96%
45,464 $11.4 Million
Q4 2018

Feb 12, 2019

BUY
$204.73 - $257.93 $201,454 - $253,803
984 Added 2.17%
46,375 $10.4 Million
Q3 2018

Nov 05, 2018

SELL
$233.07 - $256.0 $326,298 - $358,400
-1,400 Reduced 2.99%
45,391 $11.8 Million
Q2 2018

Aug 14, 2018

SELL
$208.1 - $233.85 $228,701 - $257,001
-1,099 Reduced 2.29%
46,791 $11.2 Million
Q1 2018

Apr 30, 2018

BUY
$205.46 - $240.27 $850,398 - $994,477
4,139 Added 9.46%
47,890 $10.4 Million
Q4 2017

Feb 12, 2018

BUY
$189.0 - $222.64 $244,377 - $287,873
1,293 Added 3.05%
43,751 $9.37 Million
Q3 2017

Nov 13, 2017

BUY
$186.89 - $198.9 $420,502 - $447,525
2,250 Added 5.6%
42,458 $8.32 Million
Q2 2017

Aug 14, 2017

BUY
N/A
40,208
40,208 $0

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.